dsm-firmenich reported a 5% like-for-like sales increase in the first half of 2026, with second-quarter growth accelerating to 6%. Adjusted EBITDA reached €900 million, and the company confirmed its full-year outlook, expecting like-for-like sales growth at the higher end of its 2-to-4% target range and an adjusted EBITDA margin of around 20%. Core adjusted earnings per share rose 14% to €1.84. The company also highlighted progress on its 2026-2028 action plan, a successful dual listing on the SIX Swiss Exchange in May, and a €500 million share buyback program that was about 62% complete as of late July.
DSM-Firmenich AGReported 5% like-for-like sales growth, raised EBITDA margin outlook, and announced €500M buyback.